A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis
Clinical trial NCT03818035 · COMPLETED
Trial details
- NCT number
- NCT03818035
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-08
- Primary completion
- 2022-03-07
- Enrollment
- 880
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.